CA
NZ
UK
AU
IND
US
…
Coty Inc., together with its subsidiaries, manufactures, markets, distributes, and sells branded beauty products in the United States and internationally. It operates through two segments: Prestige and Consumer Beauty. The company provides fragrances, color cosmetics, and skin and body care products. It offers prestige products through prestige retailers, including perfumeries, department stores, e-retailers, direct-to-consumer websites, and duty-free shops under Burberry, Calvin Klein, Chloe, Davidoff, Escada, Etro, Gucci, Hugo Boss, Infiniment Coty Paris, Jil Sander, Joop!, Kylie Cosmetics by Kylie Jenner, Lancaster, Marc Jacobs, Orveda, philosophy, and Tiffany & Co. brands. The company provides beauty products through hypermarkets, supermarkets, drug stores, pharmacies, mid-tier department stores, traditional food and drug retailers, and e-commerce retailers under the Adidas, David Beckham, Bozzano, Bourjois, Bruno Banani, CoverGirl, Jovan, LeGer by Lena Gercke, Max Factor, Mexx, Monange, Nautica, Paixao, Rimmel, Risque, Vera Wang, and Sally Hansen brands. It also sells its products through third-party distributors. Coty Inc. was founded in 1904 and is headquartered in New York, New York. Coty Inc. operates as a subsidiary of JAB Beauty B.V.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
Coty Inc is a global beauty company that develops, manufactures and markets fragrances, cosmetics and skin-care products across mass and prestige channels. Long-term growth may be supported by portfolio strengthening, expansion in premium segments and e-commerce penetration alongside scale in global distribution. Investors may find the company attractive for its recognizable brand base and potential margin improvement from cost discipline and portfolio optimization.
Material risks include significant leverage and cash-flow sensitivity to shifting consumer preferences, intense competitive pressures and reliance on licensing arrangements that could affect revenue stability.
Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.
| Breakdown | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
| Income before tax | -610.20M | -344.80M | 204.50M | 704.80M | 426.80M |
| Minority interest | -14.60M | -17.70M | -20.00M | -1.80M | -5.10M |
| Net income | -604.80M | -367.90M | 89.40M | 508.20M | 259.50M |
| Selling general administrative | 3107.90M | 1529.70M | 1537.40M | 2818.30M | 2881.30M |
| Selling and marketing expenses | - | 1574.40M | 1625.50M | - | - |
| Gross profit | 3652.00M | 3820.90M | 3939.20M | 3547.30M | 3369.20M |
| Reconciled depreciation | 482.20M | 420.00M | 421.10M | 426.70M | 516.40M |
| Ebit | -455.00M | 529.90M | 582.90M | 956.20M | 690.40M |
| Ebitda | 27.20M | 949.90M | 1004.00M | 1382.90M | 1206.80M |
| Depreciation and amortization | 482.20M | 420.00M | 421.10M | 426.70M | 516.40M |
| Non operating income net other | - | - | - | 419.00M | 409.90M |
| Operating income | -81.50M | 241.10M | 546.70M | 543.70M | 690.40M |
| Other operating expenses | 5888.10M | 5651.80M | 5571.30M | 5016.90M | 5023.90M |
| Interest expense | 155.20M | 227.00M | 251.60M | 257.90M | 224.00M |
| Tax provision | -20.00M | 5.40M | 95.10M | 181.60M | 164.80M |
| Interest income | 18.40M | 16.60M | 16.10M | 15.40M | 7.20M |
| Net interest income | -165.80M | -210.40M | -235.50M | -257.90M | -224.00M |
| Non recurring | - | - | - | -6.50M | 24.90M |
| Income tax expense | -20.00M | 5.40M | 95.10M | 181.60M | 164.80M |
| Total revenue | 5806.60M | 5892.90M | 6118.00M | 5554.10M | 5304.40M |
| Total operating expenses | 3733.50M | 3579.80M | 3392.50M | 3010.10M | 3088.70M |
| Cost of revenue | 2154.60M | 2072.00M | 2178.80M | 2006.80M | 1935.20M |
| Total other income expense net | -528.70M | -585.90M | -342.20M | 425.50M | -263.60M |
| Discontinued operations | - | - | - | - | 5.70M |
| Net income from continuing ops | -590.20M | -350.20M | 109.40M | 523.20M | 262.00M |
| Net income applicable to common shares | - | - | - | 495.00M | 61.20M |
| Preferred stock and other adjustments | - | - | - | 13.20M | 198.30M |
| Breakdown | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
| Total assets | 10200.40M | 11907.70M | 12082.50M | 12661.60M | 12116.10M |
| Intangible assets | 2775.60M | 3214.80M | 3565.60M | 3798.00M | 3902.80M |
| Other current assets | 373.20M | 237.90M | 256.20M | 553.60M | 46.00M |
| Total liab | 6821.30M | 7952.10M | 7834.80M | 8428.30M | 8558.10M |
| Total stockholder equity | 3132.10M | 3685.10M | 3969.50M | 3953.50M | 3296.90M |
| Other current liab | 585.90M | 513.60M | 457.50M | 1216.80M | 1242.70M |
| Common stock | 9.70M | 9.60M | 9.60M | 9.10M | 9.00M |
| Capital stock | 152.10M | 152.00M | 152.00M | 151.50M | 151.40M |
| Retained earnings | -5878.20M | -5266.40M | -4898.50M | -4987.90M | -5496.10M |
| Other liab | - | - | - | 1265.00M | 1300.50M |
| Good will | 3809.70M | 4062.20M | 3905.70M | 3987.90M | 3914.70M |
| Other assets | - | - | - | 755.50M | 737.70M |
| Cash | 176.10M | 257.10M | 300.80M | 246.90M | 233.30M |
| Total current liabilities | 2540.50M | 2538.30M | 2601.80M | 2736.80M | 2565.60M |
| Current deferred revenue | - | - | 17.80M | 17.40M | 31.60M |
| Net debt | 3262.20M | 3988.10M | 3820.50M | 4236.70M | 4481.00M |
| Short term debt | 79.60M | 67.90M | 60.80M | 57.90M | 23.00M |
| Short long term debt | 14.40M | 3.50M | 3.00M | 57.90M | 23.00M |
| Short long term debt total | 3438.30M | 4245.20M | 4121.30M | 4483.60M | 4714.30M |
| Other stockholder equity | 9578.50M | 9532.90M | 9511.10M | 9452.30M | 9359.50M |
| Property plant equipment | - | - | - | 712.90M | 715.50M |
| Total current assets | 1917.70M | 1953.30M | 1963.50M | 2051.70M | 1681.90M |
| Long term investments | 0.00M | 1002.00M | 1090.60M | 1068.90M | 842.60M |
| Net tangible assets | - | - | - | 59.10M | -548.00M |
| Short term investments | - | - | - | 0.00M | - |
| Net receivables | 529.70M | 663.80M | 642.40M | 360.90M | 364.60M |
| Long term debt | 3033.40M | 3955.50M | 3841.80M | 4178.20M | 4409.10M |
| Inventory | 838.70M | 794.50M | 764.10M | 853.40M | 661.50M |
| Accounts payable | 1875.00M | 1890.00M | 1997.60M | 1444.70M | 1268.30M |
| Noncontrolling interest in consolidated entity | - | - | - | 186.30M | 191.30M |
| Accumulated other comprehensive income | -720.30M | -733.40M | -795.10M | -662.40M | -717.90M |
| Common stock total equity | - | - | - | 9.10M | 9.00M |
| Retained earnings total equity | - | - | - | -4987.90M | -5496.10M |
| Non currrent assets other | 820.50M | 138.90M | 92.10M | 165.60M | 85.90M |
| Non current assets total | 8282.70M | 9954.40M | 10119.00M | 10609.90M | 10434.20M |
| Capital lease obligations | 248.10M | 286.20M | 276.50M | 247.50M | 282.20M |
| Long term debt total | - | - | - | 4178.20M | 4409.10M |
| Breakdown | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
| Investments | -30.70M | -128.40M | -226.20M | -118.20M | 230.60M |
| Change to liabilities | - | - | - | 141.70M | 341.20M |
| Total cashflows from investing activities | 539.00M | -128.40M | -226.20M | -118.20M | 269.70M |
| Net borrowings | -888.70M | -120.70M | -327.50M | -268.20M | -760.70M |
| Total cash from financing activities | -1161.20M | -426.80M | -336.70M | -469.30M | -1034.00M |
| Change to operating activities | - | - | - | -140.30M | 18.90M |
| Net income | -590.20M | -350.20M | 109.40M | 523.20M | 267.70M |
| Change in cash | -81.50M | -50.20M | 36.80M | 20.00M | -46.60M |
| Begin period cash flow | 270.40M | 320.60M | 283.80M | 263.80M | 310.40M |
| End period cash flow | 188.90M | 270.40M | 320.60M | 283.80M | 263.80M |
| Total cash from operating activities | 537.80M | 492.60M | 614.60M | 625.70M | 726.60M |
| Issuance of capital stock | 0.00M | 0.00M | 355.90M | 0.90M | 0.00M |
| Depreciation | 482.20M | 420.00M | 421.10M | 426.70M | 516.40M |
| Other cashflows from investing activities | 9.30M | 86.60M | 19.00M | 104.60M | 213.20M |
| Dividends paid | 13.20M | 13.30M | 13.40M | -13.70M | -57.20M |
| Change to inventory | -50.50M | 4.80M | 67.20M | -180.30M | -48.30M |
| Change to account receivables | -5.40M | -81.10M | -104.50M | 36.80M | -77.20M |
| Sale purchase of stock | - | - | - | 1600.10M | -16.90M |
| Other cashflows from financing activities | -259.30M | -292.80M | -351.70M | -1788.40M | -255.70M |
| Change to netincome | - | - | - | 23.70M | 138.70M |
| Capital expenditures | 189.60M | 215.00M | 245.20M | 222.80M | 174.10M |
| Change receivables | - | - | - | 36.80M | -77.20M |
| Cash flows other operating | - | - | - | -346.10M | -411.90M |
| Cash and cash equivalents changes | - | - | - | 38.20M | -37.70M |
| Change in working capital | -73.30M | -312.80M | -187.60M | -85.50M | 125.60M |
| Stock based compensation | 46.30M | 50.00M | 88.80M | 135.90M | 195.50M |
| Other non cash items | 827.70M | 773.10M | 192.70M | -430.90M | -390.70M |
| Free cash flow | 348.20M | 277.60M | 369.40M | 402.90M | 552.50M |
Sector: Consumer Defensive Industry: Household & Personal Products
|
Stock Name
|
Change
(USD) |
Price
(USD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| COTY Coty Inc |
0.06 1.86% |
3.29 | - | 8.12 | 0.40 | 0.80 | 0.97 | 100.66 |
| PG Procter & Gamble Company |
-0.69 0.43% |
159.23 | 23.58 | 22.62 | 4.07 | 7.24 | 4.40 | 16.08 |
| LRLCF L'Oréal S.A |
5.40 1.11% |
492.10 | 41.14 | 34.25 | 6.52 | 8.59 | 6.67 | 27.76 |
| LRLCY L’Oreal Co ADR |
-1.57 1.61% |
95.87 | 32.44 | 25.64 | 5.16 | 6.03 | 4.79 | 19.51 |
| UL Unilever PLC ADR |
-0.56 0.85% |
65.05 | 21.53 | 16.39 | 2.66 | 7.29 | 2.77 | 12.45 |
Coty Inc., together with its subsidiaries, manufactures, markets, distributes, and sells branded beauty products in the United States and internationally. It operates through two segments: Prestige and Consumer Beauty. The company provides fragrances, color cosmetics, and skin and body care products. It offers prestige products through prestige retailers, including perfumeries, department stores, e-retailers, direct-to-consumer websites, and duty-free shops under Burberry, Calvin Klein, Chloe, Davidoff, Escada, Etro, Gucci, Hugo Boss, Infiniment Coty Paris, Jil Sander, Joop!, Kylie Cosmetics by Kylie Jenner, Lancaster, Marc Jacobs, Orveda, philosophy, and Tiffany & Co. brands. The company provides beauty products through hypermarkets, supermarkets, drug stores, pharmacies, mid-tier department stores, traditional food and drug retailers, and e-commerce retailers under the Adidas, David Beckham, Bozzano, Bourjois, Bruno Banani, CoverGirl, Jovan, LeGer by Lena Gercke, Max Factor, Mexx, Monange, Nautica, Paixao, Rimmel, Risque, Vera Wang, and Sally Hansen brands. It also sells its products through third-party distributors. Coty Inc. was founded in 1904 and is headquartered in New York, New York. Coty Inc. operates as a subsidiary of JAB Beauty B.V.
| Name | Title | Year Born |
|---|---|---|
| Ms. Sue Y. Nabi | CEO & Director | 1968 |
| Mr. Laurent Mercier | Chief Financial Officer | 1970 |
| Ms. Kristin Ely Blazewicz | Chief Legal Officer, Gen. Counsel & Sec. | 1979 |
| Mr. Gordon Von Bretten | Chief Transformation Officer | 1973 |
| Ms. Anna Von Bayern | Chief Corp. Affairs Officer | 1978 |
| Dr. Shimei Fan | Chief Scientific Officer | NA |
| Ms. Olga Levinzon | VP of Investor Relations | NA |
| Ms. Anne Jaeckin | Chief HR Officer | NA |
| Ms. Peggy Elsrode | Sr. VP of North America Luxury | NA |
| Mr. Alexis Vaganay | Chief Commercial Officer of Consumer Beauty | NA |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.
Download a free report with stock ideas and industry insights for general information.
Download Free Report Now →
Basic Materials
+1.59%
Communication Services
+0.05%
Consumer Cyclical
+0.14%
Consumer Defensive
-0.43%
Energy
-0.03%
Financial Services
+0.19%
Financials
-0.35%
Healthcare
+1.05%
Industrials
+0.67%
Real Estate
-0.25%
Technology
+1.31%
Utilities
+0.32%
Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.
Portfolio
Watchlist
Please wait processing your request...